As molecular imaging transitions from undercard modality to mainstream tool in diagnostic imaging, the reality of personalized healthcare appears to be on the horizon. An increasing limelight placed on the modality has attracted both investors and new companies, leading to significant milestones in R&D and thus fulfilling the promise of “true” personalized medicine.
If you enjoy this content, please share it with a colleague
- Read more about Molecular Imaging: Ready for the Limelight
- Log in or register to post comments